Back

Sub-Regional Corpus Callosum Morphology in Marijuana Users

Bedggood, M. J.; Kurth, F.; Luders, E.; Pedersen, M.

2025-03-11 radiology and imaging
10.1101/2025.03.10.25323638 medRxiv
Show abstract

IntroductionThe primary psychoactive component in marijuana is tetrahydrocannabinol (THC), which acts on receptors, such as cannabinoid 1 (CB1), that are distributed broadly throughout the brain. THC interferes with synaptic plasticity and neurogenesis and impacts the brains macrostructure, specifically white matter where CB1 receptors are abundant. The current study aims to investigate whether callosal morphology differs depending on how much experience individuals have with marijuana. MethodsThis is a quantitative between-group corpus callosum morphology analysis using cohort study data. The data for this study (n = 144) came from the S1200 Release from the Washington University - University of Minnesota Human Connectome Project Consortium (WU-Minn HCP). Marijuana use was quantified using self-reports and grouped as (1) no use, (2) low use, and (3) high use. T1-weighted MRI brain images were obtained and then processed using SPM12 and MATLAB. Each corpus callosum was manually traced and automatically separated into seven callosal areas according to the Witelson parcellation scheme. The resulting area measures were compared between the three groups, while covarying for total brain volume. ResultsOur ANCOVA analysis was significant (F(2, 145) = 4.38, p = .014), and posthoc tests revealed a significantly smaller anterior midbody in the high marijuana use group compared to the no marijuana use group (p = .012). ConclusionSmaller callosal areas in the high use marijuana group suggest that heavy cannabis may be related to weaker interhemispheric connectivity. Future research is required to replicate the current findings using well-powered designs.

Matching journals

The top 8 journals account for 50% of the predicted probability mass.

1
NeuroImage: Clinical
144 papers in training set
Top 0.2%
11.6%
2
Journal of Psychopharmacology
17 papers in training set
Top 0.1%
9.5%
3
Psychiatry Research: Neuroimaging
18 papers in training set
Top 0.1%
7.7%
4
Drug and Alcohol Dependence
41 papers in training set
Top 0.2%
5.3%
5
Progress in Neuro-Psychopharmacology and Biological Psychiatry
48 papers in training set
Top 0.1%
4.2%
6
Brain Sciences
55 papers in training set
Top 0.2%
3.9%
7
NeuroImage: Reports
29 papers in training set
Top 0.1%
3.9%
8
Journal of Neuroscience Research
27 papers in training set
Top 0.1%
3.9%
50% of probability mass above
9
Neuroscience & Biobehavioral Reviews
43 papers in training set
Top 0.1%
3.4%
10
Journal of Affective Disorders Reports
11 papers in training set
Top 0.1%
3.2%
11
BMC Psychiatry
25 papers in training set
Top 0.3%
3.1%
12
Schizophrenia Research
35 papers in training set
Top 0.2%
3.1%
13
Psychological Medicine
88 papers in training set
Top 0.8%
3.1%
14
Brain and Behavior
43 papers in training set
Top 0.4%
2.3%
15
Neuroscience
97 papers in training set
Top 0.5%
2.3%
16
European Journal of Neuroscience
189 papers in training set
Top 1%
2.3%
17
NeuroImage
903 papers in training set
Top 4%
2.1%
18
The Journal of Neuroscience
1025 papers in training set
Top 7%
1.7%
19
Cerebral Cortex Communications
36 papers in training set
Top 0.1%
1.5%
20
Frontiers in Neuroscience
256 papers in training set
Top 4%
1.5%
21
Brain Communications
166 papers in training set
Top 3%
1.1%
22
Human Brain Mapping
329 papers in training set
Top 4%
1.1%
23
PLOS ONE
5266 papers in training set
Top 56%
1.1%
24
Addiction Biology
51 papers in training set
Top 0.6%
1.0%
25
Cerebral Cortex
396 papers in training set
Top 5%
0.8%
26
Scientific Reports
3612 papers in training set
Top 76%
0.8%
27
Neuropsychologia
85 papers in training set
Top 1%
0.8%
28
Brain Connectivity
25 papers in training set
Top 0.4%
0.8%
29
Neuropsychopharmacology
153 papers in training set
Top 3%
0.6%
30
American Journal of Psychiatry
24 papers in training set
Top 0.7%
0.6%